home > Department > Molecular Diabetic Medicine

Molecular Diabetic Medicine

Research Topic

In type 2 diabetes, insulin resistance in insulin target organs (adipose tissue, muscle, liver, etc.) leads to failure of compensatory insulin secretion in pancreatic beta cells. Our research group focuses on insulin target organs and pancreatic beta cells involved in the pathogenesis of type 2 diabetes, using genetically engineered mouse models and clinical specimens to analyze the mechanisms of glucose metabolism homeostasis and its disruption in individuals at the molecular level. The goal is to propose new therapeutic strategies for type 2 diabetes.

Major research projects include

For more information, click here.

Main Staff

Director Kohjiro Uek
Chief, Section of Integrative Physiology Motoharu Awazawa
Senior Research Fellow Naoki Kobayashi
Research Fellows Kotaro Soeda
Maya Matsushita
Visiting Research Fellows Takayoshi Sasako
Gotaro Toda
Naoko Arakawa
Yoshiko Ikushima-Matsumoto
Technical Assistant Fumiya Takahashi
Ikumi Nomura
Research Institute
Diabetes Research Center
The Research Center for Hepatitis and Immunology
International virus infectious disease research center
Project Research
National Center for Global Health and Medicin